+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Diagnostics Market - Global Forecast 2026-2032- Product Image
In-Vitro Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

In-Vitro Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904897
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In-Vitro Diagnostics Market is projected to reach USD 117.31 Billion in 2026. It is expected to continue growing at a CAGR of 6.87%, reaching USD 175.14 Billion by 2032.

In-vitro diagnostics (IVD) sit at the center of modern healthcare, enabling disease detection, therapy selection, patient monitoring, blood screening, and public health surveillance through tests performed on specimens such as blood, tissue, saliva, and urine. The sector spans clinical chemistry, immunoassays, hematology, molecular diagnostics, microbiology, point-of-care testing, companion diagnostics, and laboratory-developed test workflows.

Verified industry signals show sustained demand for faster, more decentralized, and more precise diagnostics. The World Health Organization recognizes diagnostics as essential to universal health coverage, while regulators such as the U.S. FDA and the European Commission continue to strengthen oversight for analytical validity, clinical performance, cybersecurity, and post-market evidence. As healthcare systems shift toward value-based care, IVD manufacturers, reference laboratories, hospitals, and digital health developers are competing on accuracy, turnaround time, interoperability, and real-world clinical utility.

Transformative Shifts in the IVD Landscape

The IVD landscape is being reshaped by decentralization, automation, molecular testing, and the move from volume-based testing to clinically actionable insights. COVID-19 accelerated investment in PCR, antigen, and rapid testing capacity; that infrastructure is now being redirected toward respiratory panels, antimicrobial resistance, oncology, women’s health, and chronic disease monitoring.

Regulatory transformation is equally important. The EU In Vitro Diagnostic Medical Devices Regulation (IVDR) has raised requirements for clinical evidence and notified body review, while U.S. oversight continues to evolve around laboratory-developed tests and software-enabled diagnostics. At the same time, laboratories are adopting total lab automation, sample-to-answer platforms, remote quality management, and connected point-of-care devices to reduce labor constraints and improve consistency.

Cumulative Impact of Artificial Intelligence on IVD

Artificial intelligence is becoming a practical layer across the IVD value chain rather than a standalone feature. AI supports image analysis in digital pathology and hematology, pattern recognition in molecular and proteomic data, predictive quality control, automated result interpretation, and decision support for triage or reflex testing. These applications can reduce manual review burden and improve reproducibility when validated against representative clinical datasets.

The cumulative impact of AI depends on governance. Successful adoption requires explainability, bias monitoring, cybersecurity, locked and adaptive algorithm controls, and integration with laboratory information systems and electronic health records. Regulators have authorized a growing number of AI-enabled medical devices across healthcare, signaling a clearer pathway for validated clinical AI; however, IVD leaders must prove analytical performance, clinical relevance, and continuous post-market monitoring before scaling.

Key Regional Insights Across Major IVD Markets

North America remains a high-value IVD region due to advanced laboratory networks, established reimbursement infrastructure, active FDA pathways, and high adoption of molecular diagnostics, oncology testing, and point-of-care platforms. The United States anchors innovation through reference laboratories, academic medical centers, and diagnostics-focused investment, while Canada emphasizes publicly funded testing access, quality-managed provincial laboratory systems, and standardized clinical pathways.

Europe is defined by IVDR-driven compliance, strong hospital laboratory infrastructure, and mature demand for companion diagnostics, infectious disease testing, and chronic disease monitoring. Asia-Pacific is a highly dynamic opportunity pool, supported by China’s healthcare modernization and domestic IVD manufacturing, India’s expanding diagnostic access, Japan’s aging population, South Korea’s molecular testing capability, and Australia’s high-standard clinical pathology ecosystem.

Latin America, the Middle East, and Africa are increasingly important for access-driven IVD expansion. Brazil and Mexico lead Latin American demand through hospital diagnostics, private laboratory networks, and infectious disease testing needs. GCC countries in the Middle East are investing in hospital modernization, genomic medicine, and national screening programs, while African markets are prioritizing infectious disease diagnostics, decentralized testing, blood safety, and donor-supported public health programs aligned with WHO essential diagnostics priorities.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is expanding as Indonesia, Vietnam, Thailand, Malaysia, the Philippines, and Singapore improve hospital capacity, private diagnostics networks, and infectious disease surveillance. Procurement sensitivity remains high across several ASEAN markets, making scalable, easy-to-use, and service-supported IVD platforms essential for regional adoption.

The European Union is shaped by harmonized but more demanding IVDR requirements, creating opportunities for organizations with strong clinical evidence, quality systems, and notified body readiness. GCC countries are adopting advanced diagnostics to support national health transformation agendas, preventive screening, and specialist care expansion, while BRICS economies combine large patient populations with rising domestic manufacturing, public health testing needs, and growing molecular diagnostics demand.

G7 markets remain the benchmark for premium IVD innovation, reimbursement sophistication, companion diagnostic adoption, and advanced laboratory automation. NATO-aligned healthcare systems, particularly in Europe and North America, are also prioritizing resilient diagnostic supply chains, laboratory surge capacity, biosurveillance, and biosecurity-linked readiness after pandemic-era disruptions.

Key Country Insights Shaping IVD Demand

The United States leads IVD innovation with strong demand for molecular diagnostics, oncology companion diagnostics, decentralized testing, and high-throughput laboratory automation. Canada prioritizes quality, equitable access, and provincial procurement efficiency, while Mexico benefits from private laboratory growth and nearshoring-linked healthcare investment. Brazil is Latin America’s largest healthcare market, with demand spanning infectious disease, chronic disease, blood screening, and hospital-based diagnostics.

In Europe, the United Kingdom remains influential in genomics, infectious disease surveillance, and National Health Service laboratory modernization. Germany and France are major IVD adopters due to strong clinical infrastructure, reimbursement depth, and specialist laboratory capacity, while Italy and Spain show rising demand for chronic disease, oncology, and hospital diagnostics. Russia continues to emphasize domestic capability, essential testing access, and supply chain localization amid geopolitical constraints.

China is scaling domestic IVD manufacturing, molecular testing, and hospital diagnostics, while India is expanding affordable diagnostics through private chains, public health programs, and broader access to laboratory services. Japan’s aging population supports oncology, cardiovascular, and chronic disease testing; South Korea is strong in molecular diagnostics, digital health integration, and export-oriented innovation; and Australia maintains a high-quality pathology market with demand for automated, accredited testing and decentralized access across large geographies.

Actionable Recommendations for IVD Industry Leaders

Industry leaders should prioritize evidence generation that connects analytical performance to clinical outcomes, reimbursement value, and workflow efficiency. Products that demonstrate faster diagnosis, reduced repeat testing, improved therapy selection, better antimicrobial stewardship, or stronger population screening performance are better positioned with payers, hospitals, laboratories, and public health buyers.

Companies should also invest in regulatory readiness, AI governance, cybersecurity, and supply chain resilience. Building IVDR-compliant technical documentation, scalable quality systems, multi-region clinical validation, and interoperable digital connectivity will reduce commercialization risk. Strategic partnerships with hospitals, reference laboratories, biopharma firms, public health agencies, and regional distributors can accelerate adoption while improving local service coverage.

Research Methodology and Evidence Base

This executive analysis is built on secondary research from verified public and institutional sources, including regulatory authorities, health agencies, standards organizations, peer-reviewed literature, clinical laboratory guidance, public procurement indicators, and national healthcare policy documents. Sources considered include the WHO, U.S. FDA, European Commission, national health ministries, OECD health data, and recognized laboratory medicine associations.

The methodology triangulates regulatory developments, technology adoption patterns, disease burden indicators, healthcare infrastructure maturity, reimbursement dynamics, quality requirements, and regional access factors. Insights are validated through consistency checks across multiple source categories and are written to support strategic planning, and executive decision-making in the global in-vitro diagnostics market.

Conclusion: The Future of In-Vitro Diagnostics

The in-vitro diagnostics market is entering a more connected, evidence-driven, and regionally diversified phase. Demand is supported by aging populations, infectious disease surveillance, precision medicine, chronic disease management, antimicrobial resistance monitoring, and the need for faster clinical decisions across centralized laboratories and point-of-care settings.

Winning organizations will combine scientific credibility with operational scalability. IVD developers and laboratory stakeholders that align innovation with regulatory evidence, digital interoperability, AI governance, cybersecurity, and localized access strategies will be best positioned to support safer, faster, and more equitable healthcare delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. In-Vitro Diagnostics Market, by Offering
7.1. Introduction
7.2. Instruments
7.2.1. Analyzers
7.2.2. Automation Systems
7.2.3. Sequencing Instrument
7.3. Reagents & Kits
7.4. Services
7.4.1. Installation & Validation Services
7.4.2. Training & Consulting Services
7.4.3. Maintenance & Support Services
7.5. Software & Informatics
7.5.1. Laboratory Information Systems
7.5.2. Data Analytics & Interpretation Software
8. In-Vitro Diagnostics Market, by Test Type
8.1. Introduction
8.2. Clinical Chemistry
8.2.1. Blood Analysis
8.2.2. Electrolyte Panel
8.2.3. Liver Panel
8.2.4. Thyroid Function Panel
8.2.5. Urine Analysis
8.3. Hematology
8.4. Immunoassays
8.5. Microbiology
8.6. Molecular Diagnostics
9. In-Vitro Diagnostics Market, by Specimen
9.1. Introduction
9.2. Blood, Serum & Plasma
9.3. Saliva
9.4. Tissue Samples
9.5. Urine
10. In-Vitro Diagnostics Market, by Workflow Automation
10.1. Introduction
10.2. Manual Testing
10.3. Semi Automated Systems
10.4. Fully Automated Systems
10.5. Integrated Workcells
10.6. Total Laboratory Automation
11. In-Vitro Diagnostics Market, by Application
11.1. Introduction
11.2. Autoimmune Diseases
11.3. Cancer Detection
11.4. Cardiac Monitoring
11.5. Diabetes Management
11.6. Genetic Testing
11.7. Infectious Disease Testing
12. In-Vitro Diagnostics Market, by End User
12.1. Introduction
12.2. Academic & Research Centers
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Point-Of-Care Testing Centers
13. In-Vitro Diagnostics Market, by Patient Type
13.1. Introduction
13.2. Adults
13.3. Pediatrics
14. In-Vitro Diagnostics Market, by Region
14.1. Europe
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Africa
14.6. Middle East
15. In-Vitro Diagnostics Market, by Group
15.1. NATO
15.2. G7
15.3. European Union
15.4. BRICS
15.5. ASEAN
15.6. GCC
16. In-Vitro Diagnostics Market, by Country
16.1. United States
16.2. China
16.3. Germany
16.4. United Kingdom
16.5. Japan
16.6. India
16.7. France
16.8. Canada
16.9. Brazil
16.10. Italy
16.11. Mexico
16.12. Russia
16.13. Australia
16.14. Spain
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Abbott Laboratories
18.2. Agappe Diagnostics Ltd.
18.3. Agilent Technologies, Inc.
18.4. ARKRAY Inc.
18.5. Asahi Kasei Corporation
18.6. Becton, Dickinson and Company
18.7. Bio-Rad Laboratories, Inc.
18.8. bioMérieux SA
18.9. Danaher Corporation
18.10. DiaSorin S.p.A.
18.11. Edan Instruments, Inc.
18.12. Eurofins Scientific SE
18.13. F. Hoffmann-La Roche Ltd.
18.14. FUJIFILM Holdings Corporation
18.15. Grifols S.A.
18.16. HiMedia Laboratories Pvt. Ltd.
18.17. Hitachi High-Tech Corporation
18.18. Hologic, Inc.
18.19. Illumina, Inc.
18.20. J Mitra & Co. Pvt. Ltd.
18.21. KAINOS Laboratories, Inc.
18.22. Kyowa Medex Co., Ltd.
18.23. Labcorp Holdings Inc.
18.24. Meril Diagnostics Pvt. Ltd.
18.25. Nihon Kohden Corporation
18.26. PerkinElmer, Inc.
18.27. QIAGEN N.V.
18.28. QuidelOrtho Corporation
18.29. Revvity, Inc.
18.30. Seegene, Inc.
18.31. Sekisui Medical Co., Ltd.
18.32. Shanghai Kehua Bio-engineering Co., Ltd.
18.33. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
18.34. Siemens AG
18.35. Sysmex Corporation
18.36. Thermo Fisher Scientific, Inc.
18.37. Tosoh Corporation
18.38. Transasia Bio-Medicals Ltd.
18.39. Werfen, S.A.
List of Figures
FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SEQUENCING INSTRUMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SEQUENCING INSTRUMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SEQUENCING INSTRUMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL INSTALLATION & VALIDATION SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL INSTALLATION & VALIDATION SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL INSTALLATION & VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL TRAINING & CONSULTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL TRAINING & CONSULTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL TRAINING & CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL DATA ANALYTICS & INTERPRETATION SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL DATA ANALYTICS & INTERPRETATION SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DATA ANALYTICS & INTERPRETATION SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ELECTROLYTE PANEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ELECTROLYTE PANEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ELECTROLYTE PANEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL LIVER PANEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL LIVER PANEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL LIVER PANEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL THYROID FUNCTION PANEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL THYROID FUNCTION PANEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL THYROID FUNCTION PANEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL URINE ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL URINE ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL URINE ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL HEMATOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HEMATOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL IMMUNOASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL IMMUNOASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL MICROBIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL BLOOD, SERUM & PLASMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL BLOOD, SERUM & PLASMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL BLOOD, SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SALIVA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL TISSUE SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL TISSUE SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL TISSUE SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL URINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL URINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL MANUAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL MANUAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL MANUAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SEMI AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL SEMI AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL SEMI AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL INTEGRATED WORKCELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL INTEGRATED WORKCELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL INTEGRATED WORKCELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL TOTAL LABORATORY AUTOMATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL TOTAL LABORATORY AUTOMATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL TOTAL LABORATORY AUTOMATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL CANCER DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL CANCER DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL CANCER DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CARDIAC MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CARDIAC MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CARDIAC MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ACADEMIC & RESEARCH CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ACADEMIC & RESEARCH CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ACADEMIC & RESEARCH CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL POINT-OF-CARE TESTING CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL POINT-OF-CARE TESTING CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL POINT-OF-CARE TESTING CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL ADULTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL PEDIATRICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL PEDIATRICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL PEDIATRICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 142. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 143. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 144. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 145. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 146. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 147. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 148. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 149. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 188. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 189. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 190. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 191. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 192. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 193. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 194. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 195. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 196. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 197. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 207. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 208. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 212. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 213. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 215. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 216. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 217. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 218. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 219. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 220. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 221. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 222. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 225. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 226. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 227. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 228. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 229. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 230. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 231. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 232. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 233. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 234. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 249. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 250. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 251. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 252. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 253. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 254. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 255. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 256. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 257. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 258. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 261. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 262. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 263. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 264. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 265. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 266. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 267. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 268. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 269. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 270. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 273. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 274. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 275. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 276. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 277. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 278. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 279. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 280. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 281. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 282. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 283. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 285. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 298. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 299. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 300. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 301. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 302. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 303. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 304. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 305. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 306. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 307. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 308. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 309. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 310. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 311. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 312. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 313. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 314. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 315. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 316. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 317. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 318. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 319. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 320. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 324. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 325. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 326. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 327. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 328. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 329. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 330. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 331. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 332. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 333. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 334. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 335. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 336. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 337. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 338. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 339. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 340. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 341. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 342. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 343. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 344. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 346. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 347. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 348. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 349. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 350. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 351. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 352. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 353. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2017-2032 (USD MILLION)
TABLE 354. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 355. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 356. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 357. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 358. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 359. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 360. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 361. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 362. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABL

Companies Mentioned

  • Abbott Laboratories
  • Agappe Diagnostics Ltd.
  • Agilent Technologies, Inc.
  • ARKRAY Inc.
  • Asahi Kasei Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Edan Instruments, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • Grifols S.A.
  • HiMedia Laboratories Pvt. Ltd.
  • Hitachi High-Tech Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • J Mitra & Co. Pvt. Ltd.
  • KAINOS Laboratories, Inc.
  • Kyowa Medex Co., Ltd.
  • Labcorp Holdings Inc.
  • Meril Diagnostics Pvt. Ltd.
  • Nihon Kohden Corporation
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Revvity, Inc.
  • Seegene, Inc.
  • Sekisui Medical Co., Ltd.
  • Shanghai Kehua Bio-engineering Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Transasia Bio-Medicals Ltd.
  • Werfen, S.A.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 117.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 175.14 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned39

Related Topics

Related Reports

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions - Product Image

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

  • Report
  • 188 Pages
  • Global
From
U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease), By Test Location, By End Use, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease), By Test Location, By End Use, And Segment Forecasts, 2025 - 2030

  • Report
  • 358 Pages
  • United States
From
In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035 - Product Image

In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035

  • Report
  • North America
From
In Vitro Diagnostics Business Outlook - Product Image

In Vitro Diagnostics Business Outlook

  • Newsletter
  • Global
From
In-Vitro Diagnostics Instrument Market - Global Forecast 2026-2032 - Product Image

In-Vitro Diagnostics Instrument Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.